Original Source(s)
Related Content
Is Pharma Building the Right Facilities for Future Biologics?
As biologics portfolios expand and average product volumes fall, Miriam Monge asks whether today’s major manufacturing investments offer the flexibility tomorrow’s market will require
by Miriam Monge
November 9, 2026
-
5 min
Gene Editing Shows Promise for Alpha-1 Antitrypsin Deficiency
First liver biopsy following in vivo base editing confirms precise correction of the disease-causing mutation in Pi*ZZ AATD patient
November 11, 2026
-
3 min